Background: The use of specific triggers has been suggested to help identify patients with progressive neurological disease who would benefit from palliative care. Aim: This study aimed to improve the evidence base for the use of triggers for patients with progressive neurological disease. Design: An evaluation of palliative care services was undertaken using a retrospective case note review of the timing and presence of triggers in the last 2 years of life. Setting/participants: A total of 12 specialist palliative care units across the United Kingdom provided data from 300 patients: mean patient age 70 years, 50% male, diagnoses included motor neurone disease 58%, Parkinson's disease 17% and Parkinson's Plus syndromes 12%. Results: There was a high burden of triggers -17 in the last 2 years of life and 10 in the last 6 months of life. The most frequent triggers were deteriorating physical function, complex symptoms and dysphagia. Four factors were found to explain 64% of the total variance:
What is already known about the topic?
• • The use of triggers to identify the end-of-life phase and need for palliative care involvement for patients with progressive neurological conditions has been advocated in several policy documents. • • The triggers suggested are based on expert consensus.
• • There is a need to build an evidence base to inform and evaluate such policy recommendations.
What this paper adds?
• • The average number of triggers in the last 2 years of life was 17, with an exponential increase in the last 6 months of life.
• • Four factors explained 64% of the variance in the triggers.
• • Different triggers were associated with survival from diagnosis versus survival from referral to palliative care. Different triggers were also associated with survival for different neurological conditions.
Introduction
The care of people with neurological disease is complex and is a challenge for patients, families and professionals. There is a perceived need for palliative care for this patient group, in particular those with progressive degenerative neurological conditions (PNCs), such as motor neurone disease (MND), multiple sclerosis (MS), Huntington's disease (HD), Parkinson's disease (PD) and the Parkinson Plus syndromes (PD Plus). The need for palliative care has been discussed within specific disease guidelines 1, 2 and for all neurological patients. In the recent consensus document from the European Association for Palliative Care (EAPC) and the European Academy of Neurology (EAN), it was stressed that 'palliative care should be considered early in the disease trajectory, depending on the underlying diagnosis'. 3 Although there is a perceived need, many patients with progressive neurological disease do not receive palliative care, and the access to specialist services is more restricted than for cancer patients. 4 It has been suggested that this is due to the variability in the progression and prognosis of patients with neurological disease and the difficulty in recognising deterioration and that a patient is at the end of life. 4, 5 The National End of Life Care (NEoLC) Programme framework for end-of-life care in long-term neurological conditions suggested possible triggers for the identification of the end-of-life phase (the last 6-12 months) in this patient population. These 'triggers' are characteristics or events which have a significance within the disease progression, are readily recognised and can be easily used clinically. The triggers suggested included swallowing problems, recurring infection, marked decline in functional status, first episode of aspiration pneumonia, cognitive difficulties, weight loss and significant complex symptoms. 5 The use of such triggers has also been advocated by the Supportive and Palliative Care Indicators Tool (SPICT) 6 and the Marie Curie Triggers for Palliative Care 7 guidance which have suggested that triggers for palliative care involvement are used by service providers to improve palliative care access for such patients.
The triggers suggested by the NEoLC programme and other guidance are based on expert consensus and there has been little research in this area. It is essential that a robust evidence base is developed to inform and evaluate new palliative care policy, as was illustrated in the review of the Liverpool Care Pathway (LCP). 8 A small study from one centre evaluated the triggers suggested for PNCs and found four symptom components explained 76.8% of the variance. 9 These triggers were rapid physical decline; significant complex symptoms including pain, infection and cognitive impairment; and risk of aspiration. In order to further assess the value of the triggers, this study builds on this initial assessment and involved several centres in the United Kingdom.
The objectives of this service evaluation were to improve the evidence base for the use of these triggers and to explore (1) the frequency of triggers for palliative care involvement in PNCs in the last 2 years and 6 months of life, and therefore to identify which triggers are most burdensome for patients with PNCs; (2) whether the triggers were correlated and whether the number of triggers could be reduced to fewer components; (3) the relationship between the triggers and trigger components, and survival from diagnosis and referral to palliative care services; (4) the associations between triggers and survival for different diagnoses; and (5) the use of the proposed triggers as helpful for specialist palliative care (SPC) providers in assessing when they may have increased involvement in the care of patients with progressive neurological disease.
Methods

Study design and setting
The evaluation of the services for this patient group was undertaken using a retrospective case-note review by 12 sites from across England and Wales identified through the Association of Palliative Medicine Neurology Specialist Interest Forum (APM Neuro-SIF). All were SPC services that provide care at home, hospice unit, in a day hospice or hospital. The data had already been collected as part of routine care, and this study only undertook a further secondary analysis of these data. Following discussion with the Leeds East Health Research Ethics Committee, it was agreed that the study met the criteria for UK ethical regulations for research limited to secondary use of anonymised information previously collected in the course of normal care and did not require review by the research ethics committee. Individual sites that collected data confirmed in writing that they followed local governance procedures. Data for the evaluation were extracted between January 2014 and 2015.
Participants
Consecutive patients who had a diagnosis of a PNC, who were under the care of a SPC service, and who had died between January 2009 and 2014 were eligible for inclusion. The local sites identified all participants.
Data sources
Members of the clinical team extracted data from the patients' clinical records, including paper case-notes from hospices, hospitals and community teams, as well as electronic databases. A standardised data collection form and a data collection guideline were used to ensure consistency of data extraction across all centres. All data were anonymised locally.
Variables
Data collected included demographic details (e.g. age, gender and ethnicity) and medical history (diagnosis, date of diagnosis, number of comorbidities, date of palliative care referral). For each trigger, according to documented evidence, the timing (in units of months prior to death) of the first presentation and subsequent deterioration of the trigger over the last 2 years of life were extracted. In addition to the triggers assessed by Hussain et al., 9 respiratory symptoms were also included as a trigger as this was considered by the APM Neuro-SIF as a potential important trigger for palliative care involvement in PNCs, and in particular MND.
Analysis
Descriptive data are summarised by the mean (standard deviation (SD)) or number (%). Principal component analysis (PCA) was used to assess the correlation between the triggers and to identify common components and therefore whether the triggers could be reduced to fewer components. In this type of analysis, the correlation between parameters (triggers) is attributed to their common dependence on independent entities called 'factors'. The coefficients that link parameters to factors are called 'factor loadings'; the number of factors is chosen to be as small as possible but large enough to account for most of the variation within the data. PCA was conducted using data from the last 6 months as there was evidence that the number of triggers increased rapidly after this point and to optimise the number of complete cases. It was decided a priori that the number of factors in the varimax rotation would be based on the number of eigenvalues >1.0 in the PCA. We adopted one common and conventional rule of thumb to consider 'factor loadings' of 0.40 or larger to be 'high'. Tests of multicollinearity (Bartlett's test of sphericity p < 0.05) and sampling adequacy (Kaiser-MeyerOlkin (KMO)) were undertaken to check the analysis was appropriate. The internal consistency and reliability of the factors were assessed using Cronbach's α. The least squares regression approach was used to calculate the factor scores, which are standardised to a mean of zero. The factor scores may then be used as variables in subsequent modelling. 10 Univariable and multivariable (adjusted for age, gender, diagnosis and comorbidities) Cox regression analyses were used to assess the association of survival from (1) diagnosis and (2) referral, and 1. Factor scores determined by the PCA, 2. Individual triggers and the number of triggers at 3, 6 and 12 months.
The Cox regression analyses for survival from diagnosis were repeated according to whether the participants were diagnosed with MND, PD or PD Plus. Assessment of the other diagnoses was not possible as the number of participants with the diagnoses was insufficient. A p value of <0.05 was considered to indicate statistical significance, and all analyses were undertaken on STATA (v14.0).
Results
In total, 300 clinical records were reviewed retrospectively. The mean age was 70 years (range, 35%-98%), 50% were male and 92% were White. The main diagnoses were MND (58%), PD (17%), PD Plus (12%), MS (9%) and HD (2%). The majority had comorbidities (76%), with 46% having two or more comorbidities.
Frequency of triggers for palliative care involvement in PNCs in the last 2 years and 6 months of life
The average number of total triggers over the last 2 years of life was 16.7 (SD = 12.7), and in the last 6 months, it was 10.0 (SD = 7.4). Table 1 demonstrates that the most frequent triggers in both the last 2 years and 6 months of life was deteriorating physical function (2 years: 5.0 (SD = 4.0), 6 months: 2.9 (SD = 2.5)) followed by significant complex symptoms (2 years: 3.9 (SD = 5.2), 6 months: 2.3 (SD = 3.1)) and dysphagia (2 years: 2.5 (SD = 2.3), 6 months: 1.5 (SD = 1.5)). The same pattern was seen when trigger frequency was assessed per diagnosis for patients with MND, PD, and PD Plus ( Table 6 in Appendix 1). However, for those with MS, significant complex symptoms (3.0 (SD = 3.5)) were slightly more frequent than deteriorating physical function (2.8 (SD = 3.1)), and for the seven participants diagnosed with HD, cognitive impairment was the second most frequent trigger (2.0 (SD = 2.1).
In the last 2 years of life, just over half of the patients had documented evidence of weight loss (56%) and pain (56%), and in the last 6 months, the figures were just under half (weight loss 42%; pain 44%). Figure 1 illustrates the trend in the total number of triggers according to months prior to death; this demonstrates an exponential increase in the number of triggers over time, with a rapid increase in the last 6 months of life.
Principal Component Analysis
Factor analysis yielded four separate factors that explained 64% of the total variance in the data set when the eigenvalue = 1 criterion was used. Using data from the last 6 months of life, the correlation matrix is shown in Table 2 . Bartlett's test of sphericity (χ 2 = 349, degree of freedom = 36, p < 0.0001) indicated that the correlation between the variables was sufficiently large for PCA. The KMO measure of sampling adequacy was 0.68, which can be interpreted as the degree of common variance among the variables, and verified the sampling adequacy of the analysis.
Factor analysis, derived from the factor loadings and the analysis of the triggers in last 6 months of life, identified four factors, with the following groupings (Table 3) Factor 1 explained 22% of the variance, the second factor 16%, third factor 14% and the fourth 12%. Factors 2-4 only loaded on one or two items, and so must be interpreted with caution. Cronbach's α were 0.67 for Factor 1, 0.37 for Factor 2 and 0.26 for Factor 3. If 'respiratory symptoms' is excluded as a trigger, then there is evidence that weight loss, cognitive impairment and infections cluster on the same component and explained 16% of the total variance (data not shown). Higher factor scores on each factor were associated with a higher number of triggers.
Association between triggers and survival in patients with PNCs
The mean survival time from diagnosis was 56.5 months (SD = 6.3 months; 95% confidence interval (CI): 43.3, 67.8) and the median survival 24 months (interquartile range: 64, 11). The mean survival from referral to palliative care was 29.1 months (SD = 6.0 months; 95% CI: 17.4, 40.9) and the median survival was 10 months (interquartile range: 24, 3).
Survival and factor scores. In a Cox regression analysis assessing the association between the factor scores and survival from diagnosis, there was no statistically significant association at the 5% significant level. This remained the case following adjustments for age, gender, diagnosis and number of comorbidities (Table 4 ). In the Cox regression analysis assessing the association between the factor scores and survival from palliative care referral, Factor 1 had a statistically significant association (hazard ratio (HR): 0.9, 95% CI: 0.76, 0.99); this remained the case after adjusting for age, gender, diagnosis and number of comorbidities (HR: 0.86, 95% CI: 0.75, 0.99). The HR indicates that an increase in Factor 1 scores (deterioration in physical function, dysphagia, significant complex symptoms and pain) reduces the risk of death, after adjustment for the effects of the other variables in the model.
Survival and individual triggers.
In a multivariable Cox regression analysis assessing the association between individual triggers and survival from diagnosis, there was evidence that the number of triggers 3 months prior to death and diagnosis had a statistically significant association with survival from diagnosis ( Table 7 in Appendix 2). When repeated for survival from referral to palliative care, there was evidence that again the number of triggers 3 months prior to death had a statistically significant association with survival, as well as weight loss in the last 2 years of life and age. There was evidence that the number of documented episodes of cognitive impairment was also associated with survival; however, the 95% CI for this crosses 1. As age, episodes of weight loss and number of triggers at 3 months increased, the hazard of death increased (Table 7 in Appendix 2).
Association between triggers and survival for different diagnoses
Survival and factor scores. The multivariable Cox regression analyses for survival from diagnosis for the MND, PD and PD Plus groups found evidence that different factors were associated with survival for the different diagnoses (Table 5 ). For MND, there was insufficient evidence that any of the factors scores were associated with survival when age, gender and comorbidities were taken into account. For PD, there was evidence of a significant association with Factor 4 (aspiration), and for PD Plus, there was evidence of a significant association with Factor 1 (deterioration in physical function, dysphagia, significant complex symptoms and pain) and Factor 3 (recurrent infections and cognitive decline). The multivariable Cox regression analyses for survival from palliative care referral for the MND, PD and PD Plus groups also found evidence that different factors were associated with survival for the different diagnoses (Table 5 ). For MND, there was insufficient evidence that any of the factors scores were associated with survival when age, gender and comorbidities were taken into account. For PD, there was evidence of a significant association with Factors 1 and 4; and for PD Plus, there was evidence of a significant association with Factors 2, 3 and 4.
Survival and individual triggers. The multivariable Cox regression analysis assessing the association between individual triggers and survival from diagnosis found for MND that being female and the number of triggers at 3 months prior to death increased the hazard of death; for PD that increasing number of aspirations increased the hazard of death; and for PD Plus that more infections and episodes of cognitive impairment increased the hazard of death, however as the total number of triggers at 6 months increased, the hazard of death was found to decrease (Table  8 in 
Discussion
This is the largest study to date to assess the value of the triggers for palliative care involvement proposed by current palliative care policy guidance for individuals with PNCs. There was evidence of high burden of triggers in the last 2 years of life for patients with neurological conditions, with a rapid increase in the last 6 months. Four factors explained a large proportion of the variance in the triggers indicating the triggers could be grouped in fewer components. Different factors and triggers were associated with survival from diagnosis and referral to palliative care services; this was also the case when the associations were assessed for individual diagnoses. These results indicate that the association of the triggers with survival is complex and that different triggers may be more important in different PNCs. The use of triggers appears to be valuable in predicting deterioration in the last 6-12 months of life. The commonest triggers were decline in physical function, complex symptoms and dysphagia. These were found for all diagnoses. The frequency of these triggers may reflect that they are the most burdensome issues for patients, but may also reflect that the other triggers, especially weight loss and cognitive impairment, are less well assessed or documented. The total number of triggers increased as death approached and there appears to be an exponential pattern as shown in the earlier study. 9 There is a rapid change in the numbers of triggers towards death, and thus, monitoring the rate of change in the total number of triggers may be a useful prognostic tool, indicating that the person may be in the last few months of life.
The four factors that explained the most variance in the last 6 months of life could be categorised as Factor 1: deterioration of physical function (which would include deterioration in swallowing ability, development of significant complex symptoms, and pain); Factor 2: weight loss and respiratory symptoms; Factor 3: recurrent infections and cognitive impairment; and Factor 4: aspiration. These are similar to the factors identified in the previous analysis on a smaller sample. 9 Despite the larger sample in this study, the small Cronbach's alphas indicate that the results should be interpreted with caution. Current clinical understanding may not necessarily suggest these groupings, and initially, the expert group did report these triggers individually. However, the analyses in both studies have suggested similar factors, and the components do measure a large proportion of the variation in the data and therefore it would seem that the triggers could be reduced to fewer components. Further studies that collect the triggers data prospectively are now needed to reassess the factor loading before implementing changes to practice. The association between triggers and survival was complex. There was insufficient evidence that the factors derived from the PCA were associated with survival from diagnosis when all diagnoses were grouped together. However, in the PD group, Factor 4 (aspiration) had a statistically significant association with survival from diagnosis, and for the PD Plus group, both Factors 1 and 3. In terms of the individual triggers, there was evidence when all diagnoses are grouped together that the total number of triggers at 3 months was associated with survival from both diagnosis and palliative care referral. Although there was evidence that as the number of episodes of weight loss increased, the hazard of death increased when all the diagnoses were grouped together; for the MND, PD and PD Plus group, other triggers had a significant association with survival. This indicates that different triggers may be useful in aiding prognostication for different conditions; however, further research with larger samples for each diagnostic group is required.
Limitations
Data collected as part of routine clinical practice were extracted for this study; therefore, there is a risk of information bias due to inaccurate collection, interpretation or documentation of triggers. To minimise bias at the data extraction phase, detailed guidance was provided, together with email/telephone support throughout the process. In addition, healthcare professionals who were aware of the clinical context extracted data. This review focussed on triggers in the last 2 years of life and was limited to patients known to palliative care services; thus, these findings may not be generalisable to all patients with PNCs. This should be addressed in future research.
This study provides evidence that the triggers for palliative care involvement advocated by the NEoLC programme, SPICT and Marie Curie Triggers for palliative care guidance, may be helpful in the assessment of patients with PNCs and the identification of patients in the last few months of life. There is increasing evidence that palliative care can be helpful in improving symptoms and quality of life [11] [12] [13] and that the involvement of SPC should be dependent on need rather than prognosis. However, this episodic approach is a challenge for SPC services, 4, 14 and the use of triggers may be able to help in both the identification of disease burden and prognostication that death may be approaching, which would support the involvement of palliative care with such patients. It is essential, however, that the triggers suggested by experts in the field are rigorously assessed and developed to ensure patients receive optimal palliative care input. This study has helped to identify key areas for further prospective research, including how the triggers could potentially be categorised into fewer components, how the rate of change of triggers is associated with survival and which triggers are most useful for different PNCs. We would also advocate patient and carer involvement to determine which triggers for palliative care involvement warrant further assessment. 
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